PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Heart Center Freiburg University, Department of Cardiology and Angiology I, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Department of Emergency Medicine, University Hospital of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Medical Center-University of Freiburg, Department of Medicine II, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Medical Center-University of Freiburg, Division of Infectious Diseases, Department of Medicine II, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/ajh/hpaa169
?:doi
?:hasPublicationType
?:journal
  • American journal of hypertension
is ?:pmid of
?:pmid
?:pmid
  • 33043967
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.322
?:rankingScore_hIndex
  • 123
is ?:relation_isRelatedTo_publication of
?:title
  • Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all